ReviewProbiotics and antimicrobial proteins2026
The Potential Anticancer Mechanisms of Probiotics: A Comprehensive Review.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Cancer is a leading cause of mortality. With the changes in people's daily lifestyle and environmental pollution, the incidence of cancer has been increasing all over the world. Cancer not only increases patients' physical and mental burdens, but also brings a huge economic burden to the society. Thus, it is urgent to develop anti-cancer therapies with low side effects and high efficiency. Nowadays, probiotics have been considered as an effective strategy owing to their anti-tumor efficacy. In this review, we comprehensively summarize anti-cancer mechanisms of probiotics. Mechanistically, cell and animal experiments have revealed that probiotics prevent and/or alleviate cancer by blocking carcinogenesis-associated signaling pathways, initiating cancer cell apoptosis, detoxifying or reducing pro-carcinogenic compounds, regulating intestinal microbiota and their metabolites, increasing the efficacy of anti-cancer therapies, inhibiting inflammation, enhancing anti-tumor immunity, and reprogramming metabolism. Clinical evidence of probiotics in cancer treatment is also summarized. Finally, it discusses the future perspectives in the safety concerns, limitation use, and strain-specific effects of probiotics.
Indexed as
Identifiers
41134485What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.